TTCC

TTCC (T-cell Therapy and Cancer Center) is a specialized biotechnology company and clinical center focused on the development and administration of advanced cell-based immunotherapies. The company primarily works on chimeric antigen receptor T-cell (CAR-T) therapies, natural killer (NK) cell therapies, and dendritic cell vaccines to treat various hematological malignancies and solid tumors. TTCC operates with a focus on translating cutting-edge research into clinical applications, providing personalized treatment options for patients with refractory or relapsed cancers. Their business model integrates research, development, and clinical trial management to accelerate the delivery of next-generation immunotherapies.